University Of Florence
Clinical trials sponsored by University Of Florence, explained in plain language.
-
Two-Year test for new migraine pill aims to cut headache days in half
Disease control Recruiting nowThis study aims to see how well and how safely the medication rimegepant works to prevent migraines in everyday life. It will follow 100 people with frequent migraines for two years as they take the medication every other day. Researchers will track how many migraine days they ha…
Sponsor: University of Florence • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Tablet therapy aims to protect stroke Survivors' minds
Disease control Recruiting nowThis study is testing whether a home-based brain training program, delivered on a tablet, can help reduce thinking and memory problems after a stroke. It will involve 100 adults who recently had a stroke. One group will do 40 hours of brain exercises over 8 weeks, while the other…
Phase: NA • Sponsor: University of Florence • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New migraine pill aims to stop pain in 2 hours
Symptom relief Recruiting nowThis study is testing how well and how safely a medication called rimegepant works to treat migraine attacks as they happen. It will enroll 100 people with migraines to take a dissolving tablet when a migraine starts and track their pain and symptoms over several hours. The main …
Sponsor: University of Florence • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Can this infusion stop a migraine in its tracks?
Symptom relief Recruiting nowThis study is testing whether an intravenous medication called eptinezumab can stop a migraine attack while it is actively happening. It will involve 50 people who experience migraines and are already scheduled to start this treatment. Researchers will measure how quickly the mig…
Sponsor: University of Florence • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC